In summary, the prevailing research suggests that CLDN5 is related to immune infiltration, MSI, TMB, and DNA methylation in various cancers, as well as the outcomes of cancer patients and immune infiltration across diverse cancers, particularly STAD. This evidence concerns the gene CLDN5 and cancer.